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ABSTRACT 
In Vitro Identification of the Effect of Serotonin 
on Lymphocyte DNA Synthes i s and 
Natural Killer Cell Activity 
by 
Kim Kartchner Kane, Master of Science 
Utah State Uni versity, 1989 
Major Professor: Dr. Reed P. Warren 
Department: Biology 
Vll 
The purpose of this study was to identify the effects of the 
neurotransmitter, serotonin (SE), on the immune function of 
peripheral blood mononuclear cells (PBMC) of normal, healthy 
su bjects. This was done as a preliminary investigation to studies 
on the association of SE with immune changes in autistic subjects. 
The PBMC isolated from normal male subjects were treated with 
various concentrations of SE for 48 hrs. Their incubation in SE at 
a concentration of 10 -3 M induced about a 35 % decrease in DNA 
sy nthesis. However, incubation of the cells in lower concentrations 
(10 -4 to 10 -10 ) of SE produced no significant effect. The ability of 
nat ural killer (NK) cells to lyse K562 target cells was also 
ex amined after incubation with SE for 48 hrs. The NK activity was 
al most completely eliminated following incubation in 10 -3 M of SE , 
but the activity was not significantly decreased by exposure to 
lower concentrations of SE . The viability of PBMC was not altered 
following incubation with SE under identica l conditions as those 
viii 
utilized in the NK assay. 
Preliminary analysis using a fluorescence-activated cell 
sorter (FACS) of monoclonal antibodies directed against Tll (total 
T cell), T4 (helper T cell), T8 (suppressor and cytotoxic T cells), 
B-cell and NK cell markers indicated that the suppressive effect 
exerted by SE could be attributed to a decrease in the density of 
these markers or receptors on the cell surface. These findings 
provide additional evidence for a possible link between 
neurotransmitters, specifically SE, and immune function. 
(71 pages) 
CHAPTER I 
INTRODUCTION 
The immune system is viewed as being autologous and internally 
regulated by a variety of intricately controlled mechanisms that 
involve subsets of lymphocytes, monocytes, antibodies and 
lymphokines. However, studies are increasingly providing evidence 
th at factors outside the immune system provide a critical influence 
on immune function and regulation, primary among these being the 
hor mones and neurotransmitters of the central nervous system (CNS) . 
It has long been recognized that susceptibility to infectious 
disease and/or reduced immune function are associated with emotional 
stress and bereavement (Bartrop et al, 197 7; Joasoo & McKenzie, 
1976; Solomon et al., 1969; Spry, 1972), suggesting that 
psychological trauma triggers illness via a neuroimmune process. 
Also, immune abnormalities in number and function of lymphocytes and 
the production of antibodies have been detected in animals with 
e lectrolytic lesions in selected areas of the brain (Br ooks et al. , 
1982 ; Jankovic & Isakovic, 1973; Schiavi, Macris & Camerino, 1975; 
Tyrey & Nalbandov, 1972). However, defining the neuroimmune 
regu latory interaction is much more elusive than recognition of its 
ex istence. This interaction is undoubtedly very complex, involving 
regu latory mechanisms between and within the two systems whose 
coordina ted activities are necessary for optimal function. 
Various hormones and neurotransmitters have been implicated as 
intermediaries between the CNS and immune system (Abraham & Buga, 
1976; Bhathena et al., 1981; Bonnet, Lespinats & Burtin, 1984; 
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Eliseeva & Stefanovich, 1982; Fleminger, Jenner & Marsden, 1982; 
Goodwin et al., 1979; Hazum, Chang & Cuatrecasas, 1979; Loveland, 
Jarratt & McKenzie, 1981; Maslinski, Grabczewsla & Ryzewski, 1980; 
Pochet et al., 1979; Richman et al., 1981; Roszman et al., 1984; 
Vetoshkin, Fomenko & Zozulia, 1982), including the neurotransmitter 
serotonin (SE). SE exerts an effect on many physiological 
conditions , such as mood, appetite, aggressive and sexual behavior, 
hormonal regulation, sleep-wakefulness patterns, and has also been 
implicated as an immunodepressant (Bliznakov, 198 0; Devoino, Eremina 
& Ilyritchenok, 1970; Devoino et al., 1975; Jackson et al.,1985; 
Pierpaoli & Maestroni, 1978; Slauson et al., 1984; Wurtman, 1980). 
Ho wever , the specific lymphocytic subsets upon which it exerts it s 
influence remain to be elucidated. 
Autism is a syndrome that has increasingly been identified as 
a neurological disorder, but its etiology is unclear. In attempts 
to identify biochemical markers for autism , several studies have 
de mo nstrated an elevat e d level of SE in the peripheral bl oo d o f a 
s ubset of autistic patients (Hoshino et al. , 1984; Ritvo et al., 
1970). It has also been reported that a subset of autistic patients 
have depressed lymphocyte responsiveness and reduced natural killer 
(NK) cel l activity (Stubbs & Cra wf ord, 1977; Warren et al., 1986; 
Warren, Foster & Margaretten , 1987). Since SE has been observed to 
be immunosuppressive , it is of interest to determine whether there 
is any correlation between SE levels and immune changes in autistic 
patients . The purpose of this study was to provide additional 
informa tion on the in vitro effects of SE on the responsiveness of 
peripheral blood mononuclear cells (PBMC) to mitogen stimulation and 
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natural killer cell activity in healthy subjects as preliminary data 
to further studies on the possible correlation referred to above in 
the autistic patients. 
The immune system consists of a wide variety of cells and 
humoral factors that interact in a highly regulated fashi on to 
bring about the necessary defenses against harmful external and 
internal threats to optimal bodily function. Foll owing stimulation 
by antigens and/or mitogens, the class of immune cells known as 
lymphocytes undergoes transformation, a process that involv es an 
increase in various metabolic processes and, eventually, DNA 
synthesis and cell division. The utilization of this phenomenon in 
vitro provides a valuable tool to evaluate cell function and 
activity . 
One subset of lymphocytes are the NK. These large, granular 
lymphocytes react without prior exposure and sensitization 
(Herberman & Ortaldo , 1981), play an important role in the body ' s 
d e fense against tumor and virally infected cells (Bukowski et al., 
1983; Cudkowicz & Hochman, 1979; Gorelik & Herberman, 1981; Lopez 
et al., 1982; Rager - Zisman & Bloom, 1985; Su lli van et al., 1980; 
Talmadge et al., 1980; Wiltrout et al., 1984) and have been 
implicated in regulations of he mopoi etic cell development and 
function (Arai et al., 1983; Carvalho & Horwitz, 1980; Hansson et 
al ., 1982; Kiessling & Wigzell, 1979; Nabel, Allard & Cantor , 
1982; ). 
It is of interest to determine the factors that regulate NK 
cell function and development. Factors intrinsic to the immune 
sys tem, such as interferon, inter leukin-2 ( IL-2) and prostaglandins, 
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have been shown to play a role in NK regulation (Dempsey et al ., 
1982; Goto et al., 1983; Hall & Brostoff, 1983; Hersey et al. , 1981; 
Ortaldo et al., 1983a,b; Wallach, 1983), and extrinsic factors such 
as retinoic acids, the neuropeptides B-endorphin and enkephalin and 
the catecholamines have also been implicated (Crary et al., 1983; 
Goldfarb & Herberman, 1981; Mathews et al., 1983; Schattner & 
Duggan, 1985; Tonnesen, Tonnesen & Christensen, 1984). SE also 
appears to play a rol e in regulation of the immune system as 
mentioned above, but its effect on DNA transformation and 
proliferation and NK cell development and function remains 
uncertai n. 
CHAPTER II 
LITERATURE REVIEW 
Components of the immune system 
The immune system consists of 
5 
a complex network of 
lymphocytes, monocytes, lymphoid organs and tissues, lymphokines and 
other factors that all work together in an intricate pattern for 
host defense. The lymphoid organs can be divided into the central 
and peripheral components, with the central organs including the 
thymus and bone marrow and the peripheral tissues composed of the 
spleen , lymph nodes, tonsils, appendix and Peyer 's patches (Kimball, 
1983) 
The cellular components of the immune response, the 
lymphocytes and monocytes, are mobile entities that move throughout 
the body in the blood and lymph. These peripheral blood mononuclear 
cells, or PBMC, are largely responsible for recognition of and 
immune response against foreign antigens. The immune responses are 
o f two basic types: humoral and cell mediated. Humoral responses 
are mediated by specific globulin molecules known as antibodies , 
while cell-mediated responses involve lymphocytes, with monocytic 
assistance, that are specifically sensitized against the foreign 
agent (Kimball, 1983) 
The class of cells known as the lymphocytes are divided into 
two major populations: the B cells that produce the antibodies that 
provide humoral immunity and the T cells that are responsible for 
forming the sensitized lymphocytes for cellular immunity. Both 
types of lymphocytes are derived from stern cells, which must go 
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through a process of differentiation to become committed to form 
lymphocytes. However, lymphocytes that are destined to eventually 
become T lymphocytes first migrate to and are preprocessed in the 
thymus gland, while the other population of lymphocytes, those which 
will be the B lymphocytes, are processed in some unknown area of the 
body, probably the bone marrow in mammals. T lymphocytes may be 
further divided into 3 subclasses on the basis of their function: 
helper T, cytotoxic T and suppressor T. Approximately 5-10 % of PBMC 
are termed "null" cells, as they do not have the characteristics of 
either Tor B cells. This group of lymphocytes includes the killer 
or K cells, which mediate antibody-dependent cell-mediated 
cytotoxicity , and natural killer or NK cells, which are capable of 
killing target cells without prior sensitization (Kimball, 1983). 
The other group of PBMC, the adherent cells composed of 
monocytes and dendritic cells, are involved in the induction of both 
the humoral and ce ll-m ediated immune responses. Monocytes 
differentiate into macrophages, which function in phagocytosis and 
antigen-processing and -presentation. The role of the dendritic 
cells is unclear, although they are capable of stimulation of the 
mixed-lymphocyte reaction and induction of cytotoxic T cells 
(Kimball, 1983). 
Lymphokines are soluble substances or "factors" produced by 
PBMC during the course of the immune response that mediate a wide 
variety of activities in the various cells involved in the response. 
In general, these factors are products of helper T cells, are 
proteins or glycoproteins, are not usually species specific and, as 
a group, may have up to 50 activities. Lymphokines include such 
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factors as interleukin - 2 that is strongly mitogenic for helper and 
cytotoxic T cells , migration inhibition factor that inhibits 
monocyte migration, ma cro phag e activating factor that induces 
macrophage function and many others (Kimball, 1983). 
Lymphocyte transformation 
and proliferation 
Normal peripheral blood lymphocytes are resting cells until 
they are stimulated in some manner. Following this stimu l ation , the 
lymphocyte will undergo a series of changes that include: increases 
in metabolic activity , enzyme content and protein synthesis; 
enlarge ment to become a "bl ast " cell and, eventually, new DNA 
synthesis and cell division . This process is known as lymph ocyte 
transformation (Oppenheim & Schecter, 1976) 
Specific recognition of antigens induces lymphocyte 
transformation , but there is also a wide variety of agents known 
as mitogens that bind to surface receptors of the lymphocyte. These 
produce significant proliferation, often specific, that may be 
utilized for in vitro studies. Some examples of these mitogenic 
agents include the plant lectins concanavalin A (Con A), which 
stimulates both immature and mature murine thymocytes and human 
peripheral T cells but not B cells and phytohemagglutinin (PHA), 
which stimulates human T lymphocytes. Others, such as bacterial 
lipopolysaccharide , are specific for murine B ly mphocytes . Mitogens 
a ll ow significant proliferation o f lymph ocytes in vitro without 
prior sensitization in vivo (Bradley, 1980). 
The proliferative responses induced by the mitogen may be 
analyzed by adding a radioactively labelled nucleotide base, such 
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as tritiated thymidine, to the medium containing the stimulated 
cells . Those cells that are undergoing transformation and 
proliferation will incorporate the base in an amount proportional 
to their stimulation by the mitogen. The cells may be harvested and 
their radioactivity determined as a measure of the functional 
capabilities of the stimulated cells (Oppenheim & Schecter, 1976), 
providing an extremely useful tool for in vitro analysis. 
Introduction to 
natural killer cells 
In 1973 the phenomenon of natural cytotoxicity was observed in 
studies in which mononuclear cells isolated from heal thy, non-
immunized donors had the ability to lyse a variety of malignant 
cells in short-term culture (Oldham & Herberman, 1973; Takasugi, 
Mickey & Terasaki, 1973). This activity was present without 
previous sensitization of the mononuclfar cells to the target cells , 
distinguishing it from cytotoxic T cell activity, and occurred 
without a requirement for antibody, distinguishing it from 
antibody-dependent cellular cytotoxicity (ADCC). This unique 
activity and the cells capable of performing it were termed NK 
activity and NK cells, respectively. The currently accepted 
definition of NK activity is the ability of a certain subpopulation 
of lymphoid cells to identify and lyse a large variety of tumor, 
immature and virally infected cells without prior sensitization or 
MHC restriction (Herberman & Ortaldo , 1981; Kiessling et al., 1976). 
Characteristics of NK cells 
Most cells capable of NK activity have the distinct morphology 
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of large granular lymphocytes. These cells have a high nuclear 
cytoplasmic ratio, a slightly indented nucleus, are 12-15 microns 
in diameter and contain many azurophilic granules in the cytoplasm 
(Timonen, Ortaldo & Herberman, 1981) Large granular lymphocytes 
make up about 22% of the lymphocytes found in the peripheral blood 
(Abo, Cooper & Balch, 1982a). 
Specific surface markers characteristic of all NK cells have 
yet to be identified. However, subpopulations of cells mediating 
NK activity have been identified phenotypically (Abo, Cooper & 
Balch, 1982b; Minato, Reid & Bloom, 1981; Zarling et al., 1981), 
thus indicating the probable heterogeneity of this group of lymph oid 
cells. The heterogeneity of phenotype of NK cells has made it 
difficult to assign a cell lineage and may in fact indicate multiple 
lineages. All NK cells identified to date lack surface 
immunoglobulin and therefore are distinguishable from the B cell 
line (Gidlund et al., 1979; Santoli et al., 1978) Some NK cells 
express T-cell characteristics such as low-affinity receptors for 
sheep red blood cells, T-related surface antigens such as OKT8 and 
OKTlO , the Fe receptor and/or monocytic markers such as OKMl and 
B43.41 (Ab o & Balch, 1981; Ortaldo et al., 1981; Perussia et al., 
1983; Zarling et al., 1981). However, athymic nude mice have normal 
or increased NK activity (Haller et al., 1978; Reynolds et al., 
1982), indicating lack of the mature T-cell requirement for thymic 
differentiation. In addition, unlike mature T cells, NK cells do 
not express the OKT3 or OKT4 antigens and have been found to react 
with the anti-asialo GMl and OKMl like most monocytic and 
granulocytic cells (Herberman & Ortaldo, 1981; Stutman, Lattime & 
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Figarella, 1981). Even the most specific monoclonal antibodies for 
NK cells (anti-NKl.1 in mice and HNK-1 in humans) bind to a large 
variety of cells that do not exhibit NK activity (Abo et al., 
1982b). Based on these studies, it has been suggested that NK cells 
may be a) immature members of the T lymphocyte line and/or the 
monocytic line, b) cells from a variety of lineages sharing the same 
capacity or c) cells representing an unidentified cell lineage 
(Kimber & Moore, 1985; Ortaldo et al., 1981; Pollack et al., 1979). 
Mechanism of cytotoxicity 
Our understanding of the mechanism of target cell recognition 
and lysis by NK cells has increased substantially but still remains 
somewhat fragmentary. The mechanism can be resolved into a number 
of discrete stages, many of which are very similar to those observed 
in T-cell cytotoxicity. 
The first phase is very brief, about 1 min, with an absolute 
requirement for Mg2 • (Hiserodt, Britvan & Targan 1982a) and involves 
the binding of the NK cell to the target cell. Although the NK 
binding lacks the specificity required of T-cell lysis, the ability 
of the NK cells to recognize virus-infected, tumor and fibroblastic 
cells points to a requirement for the recognition of as yet poorly 
defined membrane receptors on the target cells. A wide variety of 
target structures may actually be recognized by NK cells, including 
the transferrin receptor (Baines, Lafleur & Holbein, 1983; 
Vodinelich et al., 1983), glycoproteins (Harfast et al., 1980; 
Roder, Ahrlund-Richter & Jondal, 1979a), glycolipids (Durdik et al., 
1980; Young et al., 1981) and target membrane sialic acid 
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concentration (Rooney & Munro, 1984; Werkmeister, Pross & Roder, 
1983; Yogeeswaran et al., 1981) Other factors that may affect NK 
binding and/or target cell susceptibility include the availability 
of Mg 2+ (Rager-Zisman & Bloom, 1985) and the level of 
differentiation of target cells (Gidlund et al., 1981; Stern et al., 
1980). 
The phase following recognition and binding, termed prograrruning 
for lysis, takes more time, approximately 2 hrs, and is dependent 
on Ca 2 • (Hiserodt et al., 1982a). This phase involves the 
triggering or activation of intracellular processes in the NK cells 
such as the methylation of phospholipids with a concurrent increase 
in phospholipase A2 activity (Hoffman et al., 1981) and the p ossib l e 
rearrangement of granules and other cytoplasmic organelles toward 
the site of binding with the target cell (Herberman, 1986) The 
sign ificance of these processes is not understood, but they hav e 
led to possible explanations of the lytic mechanism. The observed 
increase in phospholipid methylation combined with the ability of 
lipomodulin , a phospholipase inhibitory protein, to cause a dose -
depen dent decrease in NK cell-mediated cytotoxicity (Hattori et al., 
1983) has led t o the possibility of a requirement for the release 
o f fatty acids from the cell membrane in the induction of lysis. 
A number o f studies suggest that the lytic mechanism inv o l ves a 
sec retory event (Carpen, Virtanen & Saksela, 1982; Quan, Ishizaka 
& Bloom, 1982; Wright & Bonavida, 1982) explaining the movement of 
g ranules toward the site of binding as mentioned above. Agents 
which block Ca 2• , inhibit membrane proteases, augment intracellular 
cAMP, cause degranulation or block microtubular polymerization all 
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prevent lysis of the target cell (Carpen, Virtanen & Saksela, 1981; 
Dawson , Shipton & Moore, 1985; Hudig et al., 1981; Neighbour & 
Huberman, 1981; Quan et al., 1982; Zucker-Franklin, Yang & Fuks, 
1984) . 
cells 
From these results and other studies indicating that NK 
release soluble factors and/or granules capable of 
independently binding to target cells and causing lysis (Farram & 
Targan, 1983; Herberman, 1986; Wright et al., 1983; Wright & 
Bonavida, 1982), it has been suggested that a specific membrane 
interaction between NK and target cells triggers a secretory event 
in the effector cell that results in the release of a cytotoxic 
factor ( s) capable of specifically inducing lysis in the target 
(Herberman , Reynolds & Ortaldo, 1986; Rager-Zisman & Bloom, 1985). 
The final step in the cytotoxic mechanism is the actual lysis 
of the target cell. This event takes longer than the previous 
stages, has no requirement for Ca 2 • and/ or Mg2+, may occur in the 
absence of the NK cell (Hiserodt et al., 1982a, b; Quan et al., 
1982) and is therefore termed killer cell independent lysis (KCIL ) 
(Boekstegers & Grundmann, 1985). While details of this step are 
unclear, membrane lesions have been observed with the electron 
microscope that suggest the formation of channels or holes in the 
target membrane (Henkart & Henkart, 1982; Podack & Dennert, 1983) 
as a direct result of binding by the factor(s) discussed above. 
These holes or lesions result in the loss of integrity of the target 
cell and, therefore, in lysis (Henkart, 1986). 
Regulation of NK activity 
As with most metabolic processes, NK cell-mediated cytotoxicity 
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is under both positive and negative modulation. This regulation is 
effected by agents both endogenous and exogenous to the NK cell. 
Interferons ( IFNs) are key elements in NK activation and appear 
to exert their influence at various stages in the lytic process. All 
types of IFN have been shown to enhance, through various mechanisms, 
the cytotoxic activity of both murine and human peripheral blood NK 
cells (Claeys et al., 1982; Einhorn, Blomgren & Strander, 1978; 
Gidlund et al., 1978; Moore & Potter, 1980; Ortaldo et al., 
1983a,b) These mechanisms include recruitment and differentiation 
of pre-NK cells (Silva, Bonavida & Targan, 1980; Targan & Dorey, 
1980), enhanced efficiency of existing NK cells (Targan & Dorey, 
1980; Timonen, Ortaldo & Herberman, 1982) and increased recycling 
and interaction with multiple target cells (Ullberg & Jondal, 1981). 
NK cells, themselves, are important producers of INF following 
co ntact with a variety of target cells, providing a positive 
feedbac k loop (Djeu et al., 1982; Kasahara et al., 1982; Saksela, 
1981) . 
Interleukin-2 (IL-2), a glycoprotein produced by T lymphocytes 
that acts as a T-cell growth factor, has been observed to function 
as another NK activator (Dempsey et al., 1982; Henney et al., 1981) 
an d growth factor stimulating proliferation (Vose & Bonnard, 1983). 
However, since IL-2 also induces IFN (specifically IFN-garnrna) 
production (Kawase et al., 1983) it is unclear whether IL-2 
regulation of NK activity is mediated through IFNs or whether IL-2 
a lone is sufficient for activation. The observed production of IL - 2 
by LGLs following mitogen stimulation (Kashara et al., 1982) 
suggests the existence of another positive - feedback loop in NK 
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regulation. 
In addition to INF and IL-2, other agents that have been 
demo nstrated to augment NK activity include retinoic acids (Goldfar b 
& Herberman, 1981), the neuropeptides B-endorphin and enkephalin 
(Mathews et al., 1983; Schattner & Duggan, 1985) and catecholamines 
(Crary et al., 1983; Driscoll, 1979; Tonnesen et al., 1984). 
Our understanding of negative modulation of NK activity is 
rather fragmentary at this time. INFs play a role here also but at 
the target cell level rather than on the NK cell itself. Following 
expo sure to interferon, some NK-cell susceptible target cell 
populations demonstrate an increased resistance to lysis 
(Trinchieri, Granato & Perussia, 1981; Wallach, 1983) Various 
cell populations have been attributed with an NK-suppressive 
function including monocytes and macrophages (Bordignon et al., 
1982; Uchida, Colot & Micksche, 1984), smaller T lymph ocytes 
(Tarkkanen & Saksela, 1982), granulocytes (Kay & Smith, 1983) and 
tumor cells (Got o et al., 1983). It has been suggested that the 
various cell subsets exert their suppressive influence by production 
of prostaglandins (El, E2, and 02) (Hall & Brostoff, 1983; Merrill, 
1983). Prostaglandins act via an elevation of intra-cellular cAMP 
(Goto et al., 1983; Lanefelt et al., 1983), resulting in a marked 
reduction of NK ability to lyse target cells. Other poorly defined 
serum-borne factors have also been demonstrated to suppress NK 
activity in vitro (Barrett, Rayfield & Brent, 1982; Sibbitt, 
Froelich & Bankhurst, 1983). 
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Role of NK in vivo 
NK cells have been studied extensively as mediators in the 
body 's defense against tumor and virally infected cells (immune 
surveil lance). There is considerable evidence in the murine system 
that NK cells play an important role in tumor rejection. Variants 
of a murine melanoma cell susceptible to lysis by NK cells in vitro 
showed increased growth and metastatic capacity in beige mice that 
were genetically defective in NK cells (Roder et al., 197 9b; 
Talmadge et al., 1980). Also, in both athymic nude and normal mice, 
NK-resistant tumor cells became considerably less tumorigenic in 
vivo if they were persistently infected with virus, making them 
susceptible to lysis (Minato et al., 1979) . This effect can be 
reversed by anti-IFN serum, making the cells highly tumorigenic 
again (Reid et al., 1981; Schattner, Rager-Zisman & Bloom, 1985). 
When murine NK activity is depressed by carcinogens and other tumor 
promoters or antibodies such as anti-asialo GMl, there follows a 
co nsiderable increase in the number and spread of metastases 
(Cudkowicz & Hochman, 1979; Gorelik et al., 1982; Gorelik & 
Herberman, 1981; Hanna & Burton, 1981; Hanna & Fidler, 1980) 
Experiments with a rat mammary adrenocarcinoma (Barlozzari, 
Leonhardt & Wiltrout, 1985) have provided more direct evidence that 
NK cells are necessary for resistance against metastases of some 
tumors. When pretreated with anti-asialo GMl, rats showed a 
significant increase in the number of lung metastases. However, 
adoptive transfer of large granular lymphocytes, the population of 
lymphocytes responsible for almost all NK activity, led to the 
restoration of resistance to the development of metastases. 
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Although most studies have investigated NK activity in the blood or 
spleen , Wiltrout et al. (1984) have isolated highly purified 
preparations of large granular mouse lymphocytes from the liver 
after treatment with various immunomodulators. These 
immunomodulators stimulate a twentyfold increase in the number of 
large granular lymphocytes in the liver. 
In humans, the role of NK cells in tumor rejection is less 
clearly defined due, in part, to the problem of discerning whether 
changes in NK are a cause or effect of the tumor (Kadish et al., 
1981). Patients with Chediak-Higashi syndrome, an immunodeficiency 
syndrome displaying deficient NK-cell activity, exhibit markedly 
increased numbers of lymphoproliferative disorders (Roder et al., 
1980; Sullivan et al., 1980), providing some evidence of a role for 
NK in tumor defense in humans. 
Several studies have demonstrated NK function in the body's 
defense against viral infections. NK activity was observed to be 
t he predominant type of cell-mediated cytotoxicity against virally 
infected cells in human peripheral blood following influenza or 
herpes simplex infection (Lopez et al., 1982; Perrin, Zinkernagel 
& Oldstone, 1977) . Also, NK-resistant normal cells become 
susceptible to lysis when viral glycoproteins are bound to the cell 
membrane (Casali et al., 1981). Mice treated with anti-asialo GMl 
were found to be more susceptible to herpes simplex virus, murine 
cytomega lovirus, murine hepatitis virus and vaccinia virus, showing 
up to 500-fold more virus as well as more extensive disease or 
mortality (Biron, Turgiss & Welsh, 1983; Bukowski et al., 1983; 
Quinnan & Manischewitz, 1979; Rager - Zisman & Bloom, 1985). 
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NK cells have also been identified as immunomodulators, 
regulating hemopoietic cell development and function. This has 
been proposed as the primary role of NK cells with the ability to 
recognize certain malignant cells being a consequence of their 
regulatory function (Kiessing & Wigzell, 1979). In addition, 
several studies have suggested a suppressive role for NK in the 
antibody response. Nabel et al. (1982) found that a cloned NK-cell 
line was able to lyse LPS-activated B-cell blasts and was also 
capable of suppressing LPS-induced antibody production. Various 
studies have demonstrated that endogenous NK cells are able t o 
mediate the suppression of Ig in both humans (Arai et al., 1983; 
Brieva, Targan & Stevens, 1984) and mice (Abruzzo & Rowley, 1983; 
Robles et al., 1985) Also, the primary in vivo antibody response 
o f mice to sheep red blood cells was shown to be enhanced following 
t r e atment with anti-NKl.1 serum but was suppressed when NK cells 
we re activated using poly I:C (Pollack & Hallenbeck, 1982). 
Whil e NK ce l ls a pp e ar t o play a suppr e ssiv e r o l e in an t ib ody 
p r oduction by B ce lls, there is eviden c e o f a positive effect o n T-
ce ll function. Cells with E-rosette receptors and rec e ptors for the 
Fe p o rtion of IgG with morphology typical of LGL when activated 
e nhance mitogen- or antigen-induced T-cell proliferation (Carvalho 
& Ho rwitz, 1980; Horwitz & Garrett, 1977). More recently, studies 
have demonstrated that the LGLs (using purified samples) are, in 
fact, the cells responsible for the enhancement of T-cell 
proliferation as measured by colony formation (Pistoia et al., 
1983). Also, it has been shown that the development of allospecific 
c ytotoxic T cells is suppressed following the elimination of murine 
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NK activity with anti-asialo GMl (reviewed by Callewaert, 1985) 
Cells of other lineages and maturational stages appear to be 
regulated by NK cells also. Purified LGL can enhance blastogenic 
forming units of erythrocytes (BFU-E) formation (Pistoia et al., 
1983) or suppress hemopoiesis and granulopoiesis (Bacigalupo et al., 
1981; Hansson et al., 1982; Linch et al., 1981) under differing 
experimental conditions. NK activity has also been observed against 
immature normal cells, such as thymocytes or bone marrow cells 
(Hansson et al., 1979; Nunn, Herberman & Holden, 1977). In 
addition, diseases that are believed to be autoimmune in nature, 
such as systemic lupus erythematosus and multiple sclerosis, have 
been associated with deficient NK activity in a large proportion of 
the patients (Benczur et al., 1980; Hoffman, 1980). All these 
results suggest a regulatory role for NK cells in maintaining 
homeostasis under "normal" conditions. 
Serotonin - synthesis, 
storage and catabolism 
Serotonin (SE), 5-hydroxytryptamine, is one of the primary 
monoamine neurotransmitters in the brain. The synthesis and 
catabolism of SE are well established as reviewed by Cooper, Bloom 
& Roth ( 197 4) . Biosynthesis of SE in the adrenergic neuron begins 
with the dietary amino acid, L-tryptophan, which is converted by 
tryptophan-5-hydroxylase to 5-hydroxytryptophan in the initial and 
rate-limiting step. 5-hydroxytryptophan (SHTP) undergoes 
decarboxylation via SHTP decarboxylase to form 5-hydroxytryptamine. 
Once synthesized, SE is stored, transported or released by the 
adrenergic neuron in the course of its activity. SE is catabolized 
19 
in most tissues by monoamine oxidase to 5-hydroxyindoleacetic acid 
( 5-HIAA) or reduced to 5-hydroxytryptophol ( 5-HTOL) The major 
metabolite, 5-HIAA is excreted in the urine along with smaller 
amounts of 5-HTOL. 
melatonin. 
In the pineal gland SE is converted to 
The rate of SE synthesis and release has been shown to be 
directly affected by the tryptophan concentration (as determined by 
whole brain tryptophan concentration) available at any time 
(Wurtman, 1980), as the enzyme that catalyzes the rate-limiting 
step, tryptophan hydroxylase, is highly unsaturated (Jequier et al., 
1969) . As a result, dietary consumption (Fernstrom & Wurtman, 
1971), secretion of insulin (Fernstrom & Wurtman, 1972b) and other 
influences on plasma tryptophan concentration (Leathwood, 1987; 
Wurtman, 1980) combine to affect the rate of SE synthesis and 
release and, thereby, brain function. Plasma concentrations of 
amino acids competing with tryptophan for transport across the blood 
brain barrier also affect central tryptophan levels and, 
consequently , SE production and concentrations (Bloxam et al., 1980; 
Fernstrom & Wurtman, 1972a). 
SE and various other monoamines and their precursors are 
synthesized in the cell bodies of neurons and travel via axonic flow 
in monamine vesicles to the nerve terminals (Bloxam et al., 1980). 
From studies using human fetuses, nonhuman primates, cats and 
rabbits, it has been demonstrated that SE neuronal systems are 
similar across all mammalian lines (Parent, 1981). The distribution 
of the SE neuronal system is largely confined to the seven defined 
raphe nuclei of the brain stem (reviewed by Iverson, 1984). SE, 
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when released into synapses as a neurotransmitter or secreted into 
the extracellular spaces of the brain, is believed to affect the 
physiologic activities of a majority of brain neurons, including 
those that modulate the sensitivity of the brain to environmental 
input, sustain mood, control appetite, direct aggressive and sexual 
behavior, regulate secretion of some pituitary hormones and generate 
rhythms in sleep-wakefulness and other cyclic neural phenomena 
(Wurtman, 1980) 
In the mouse and rat, SE is contained in mast cells in a 
concentration of 0.8-1.3 pg/cell (Benditt, 1968; Jackson, et al., 
1988), but in humans the mast cells have not been shown to store SE 
under normal conditions , although SE has been reported in a human 
mastocytoma (Morishima, 1970). Human platelets store SE in a 
concentration of 0.4-0.8 pg/platelet (Sjoerdsma, 1959). In humans, 
SE is also located in the enteroendocrine cells of the mucosal layer 
of the gastrointestinal tract (Metcalfe, 1984) and in nervous 
tissues as discussed above. 
CNS influences on immune function 
The immune system traditionally has been viewed as an 
autonomous , self -regulated entity, independent of the central 
nervous system (CNS). However, in recent years, there has been a 
vast increase in the evidence of anatomical and biochemical links 
between the two systems. Nerve endings have long been known to 
occur in the various organs and tissues of the immune system , 
including the bone marrow (Kuntz & Richins, 1945), thymus (Hammar, 
1935), spleen (Livett, Geffen & Austin, 1968) and lymph nodes 
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(Giron, Crutchen & Davis, 1980). Therefore, anatomically there is 
the opportunity for direct regulation of immune function by the CNS. 
Studies of the effects of various brain lesions have shown a 
depressi ng effect on the numbers and functions of hemopoietic stem 
ce lls of the bone marrow (Hall et al., 1978) and lymphoid cells of 
the spleen, thymus and peripheral blood (Cross et al., 1980, 1984; 
Keller et al., 1980; Rozman et al., 1982). Other studies have 
demonstrated that at the peak of humoral responsiveness, changes in 
neurona l activity and transmitter synthesis occur (Besedovsky, et 
a l, 1977, 1983), indicating a two-way interaction between the 
ce ntral nervous and immune systems. Various neurological 
co nditions, such as stress , depression, schizophrenia and autism, 
have also been associated with alterations in immune function 
(Coffey, Sullivan & Rice, 1983; De Lisi et al., 1982; Marx, 1985; 
Miller , 1985; Osterweis , Solomon & Green, 1984; Schleifer et al., 
1984, 1985; Stubbs & Crawford, 1977; Warren et al., 1986; Weizman 
et al., 198 2 ). Of particular interest, Warren et al. (19 87) 
demonstrated a reduced NK-cell activity in autism. 
The mechanisms employed by the CNS for immunoregulation are not 
understood at this time. Th e relationship between brain and 
immunocompetent cells is probably complex, involving multiple 
factors and feedback-loops for coordinated optimal function. 
Studies have demonstrated the presence of receptors for a wide range 
of hormones (Abraham & Buga, 1976; Bhathena et al., 1981; Bonnet et 
al., 1984; Csaba, Sudan & Dobozy, 1977; Goodwin et al., 1979; Hazum 
et al., 1979; Helderman & Strom, 1978) and neurotransmitters 
(Eliseeva & Stefanovich, 1982; Fleminger et al., 1982; Loveland et 
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al., 1981; Maslinski et al., 1980; Pochet et al., 1979; Richman et 
al., 1981; Roszman et al., 1984; Vetoshkin et al., 1982; Watanabe, 
Lai & Yoshida, 1981) on monocytic and/or lymphocytic surface 
membranes, thereby providing possible intermediaries between the two 
systems. The effects of hormones, such as the glucocorticoids, on 
the immune system have been studied extensively (Cupps & Fauci, 
1982), but the effects of neurotransmitters, including SE, on immune 
function is not understood. 
Serotonin and immune function 
It has been known for years that pharmacologic enhancement of 
SE metabolism suppresses the immune response in vivo (Bli znakov , 
1980; Devoino, Korovina & Ilyritchenok, 1968; Devoino et al., 1970, 
1975; Pierpaoli & Maestroni, 1978) In 1973, Eremina and Devoino 
observed the enhancement of humoral response to bovine serum albumin 
follow i ng electrolytic lesioning of serotonergic neurons in the 
midbrain raphe nucleus, suggesting an inhibitory function for SE in 
immunoregulation. Based on this information and the finding that 
the suppression can be eliminated by hypophysectomy (Devoino et al., 
1975), it may be postulated that the effects of SE are mediated via 
a central serotonergic hypothalamic-pituitary pathway. Bliznakov 
(198 0) demonstrated that corticosterone (an immunosuppressi ve agent) 
is not a significant part of this regulatory system because SE is 
still su ppressive in adrenalectomized animals. Jackson et al. 
( 1985) found that systemic administration of SE or its precursor, 
5-hydr o xytryptophan, results in dose-dependent suppression of both 
the IgM and IgG plaque-forming cell (PFC) response to sheep red 
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blood cells, independent of observed changes in plasma 
corticosterone levels. Also, para-chlorophenylalanine (PCPA) (which 
inhibits the rate-limiting enzyme, tryptophan hydroxylase, in SE 
synthesis) was associated with a marked enhancement of IgM and IgG 
antibody production. However, this same group reported that immune 
function was not altered following specific destruction of 
serotonergic neurons via intracisternal injection of 5,7-
dihydroxytryptamine, a neurotoxin, suggesting that immunomodulation 
by SE is mediated by peripheral mechanisms involving the lymphocyte 
and/ or monocyte directly. Further studies will be necessary to 
resolve these conflicting findings on the mechanism involved. 
If SE has an inhibitory effect on immune responsiveness, an 
increase in immune responsiveness would be expected with a decrease 
in the levels of SE. This was demonstrated in a study in which 
endogenous SE was reduced by the administration of PCPA prior to 
sensitization to bovine serum albumin (reviewed by Hall & Goldstein, 
1985) . IgM and IgG levels were both found to be elevated. Segal 
and Timaras (1976) also found these same increases following 
administration of a tryptophan-deficient diet to rats. These 
animals lived longer, had a more healthy appearance and had a 
delayed onset of tumor growth in comparison with the control rats 
fed a normal diet. 
Knowledge of SE' s specific effect on macrophages and the 
various lymphocytic subsets, such as NK cells , remains fragmentary 
at this time. Although preliminary investigations indicate that 
lymphocytes have high-affinity Sl receptors and macrophages lower 
affinity S2 receptors (Roszman et al., 1984), further study is 
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necessary to determine the nature of these receptors, which subsets 
carry the receptors and their possible immunoregulatory role. As 
indicated above, studies have demonstrated an inhibitory effect, in 
vivo, on the plaque-forming cell response following immunization 
with SE (Boranic et al., 1983; Jackson et al., 1985). However, here 
again the specific cell groups being affected remains unclear. It 
has been demonstrated in vivo that administration of SE produces a 
marked depressi on of the T-cell dependent, humoral, hemolytic 
primary immune response in mice (Bliznakov, 1980) and that SE can 
stimulate chemotactic mediator production by human PBMC (Foon et 
al. , 1976) Slauson et al. (1984) has shown that SE functions early 
in the activation phase of the lymphocyte cell cycle to affect 
proliferation inhibition, works independently of IL-2 production, 
is noncytotoxic at high (10- 3 M) concentrations and produces a 
decrease in the distribution and expression of IL-2 receptors on 
responding lymphocyte surfaces. The authors of this study have 
s uggested that this inhibition is occurring at the level of the T 
lymphocyte. However, involvement of other lymphocytic and monocytic 
cells is again uncertain. Since the immune system is autoregulated 
to a great extent it is of interest to determine if other cell 
populations are also affected by SE or if the inhibitory effect of 
SE on immune function is a secondary effect of the inhibition of 
only one - or two-cell populations. 
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CHAPTER III 
MATERIALS AND METHODS 
Subjects 
This study included 2 6 randomly selected heal thy male subjects, 
ranging in age from 23-44 years and having a mean age of 32 years. 
Subjects were required to fast for 10 hrs prior to having their 
blood drawn between 8:00 and 8:30 a.m. Sixty ml of blood were drawn 
from the subjects into 1.2 ml (1000 units/ml) of preservative-free 
heparin (Sigma) following informed-consent procedures. 
Preparation of peripheral 
blood mononuclear cells 
The peripheral blood mononuclear cells (PBMC) were isolated 
from the whole blood by the use of a Ficoll-Histopaque 1077 (Sigma) 
density gradient as follows. The whole blood was centrifuged for 
15 min at 500 x gin an IEC/CU5000 centrifuge, and approximately two 
thirds of the plasma was removed and discarded. The remaining 
plasma and the buffy coat cells were removed and diluted to 35 ml 
with warm RPMI-1640 (Sigma) and the red blood cell pellet was 
discarded. Three ml of Ficoll-Histopaque 1077 were pipetted into 
five, 15-ml centrifuge tubes and 7 ml of the cell suspension were 
layered over the ficoll, taking care not to disrupt the interface. 
The tubes were centrifuged for 20 min at 900 x g resulting in the 
layers as follows from the top of the tube: aqueous layer, 
monocytes and lymphocytes at the interface, Ficoll layer and red 
blood cells, polymorphonuclear cells, etc. in the bottom layer. 
Using a Pasteur pipet, the monocyte/lymphocyte layer was pipetted 
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into a separate 15-ml centrifuge tube and suspended in 15 ml RPMI-
1640. The cells were centrifuged for 10 min at 500 x g, and the 
supernatant was poured off. Two additional washes were performed 
by add~ng 15 ml RPMI-1640 and centrifuging at 220 x g for 5 min and 
pouring off the supernatants. The PBMC were resuspended in RPMI-
1640 supplemented with penicillin (100 units/ml}, streptomycin (100 
mcg/ml ) and 20% fetal bovine serum (FBS} ( Hy clone Laboratories, 
Logan, UT) . 
Blastoqenesis assay 
The mitogen, phytohemagglutinin (PHA) (Gibco), was diluted to 
a concentration of 2 % in RPMI-1640. PHA, 0.05 ml of 2 %, 1%, 0.5 % 
and 0%, was added to triplicate wells of 96-well, flat-bottom, 
tissue-culture plates for each serotonin (SE) (creatinine sulfate 
comp le }:, Sigma) concentration. PBMC diluted to 2 X 10 6 cells/ml in 
RPMI-lf40 supplemented with 20 % FBS were added in 0.1 ml aliquots 
to eac h well. Appropriate concentrations of SE, in O. 05 ml 
aliquots, were added to each well including control wells with RPMI-
1640 ard SE and RPMI-1640 alone. Plates were incubated for 42 hrs 
in 5% :::02 at 37°C , followed by the addition of 2 X 10 -3 ml ( 0. 2 
mCi/ml) 3 H-thymidine to each well, and incubation was continued for 
an additional 6 hrs under the same conditions. The cells from each 
well wEre harvested onto filter paper, washed for 20 sec and dried 
for 15 sec with a Titertek cell harvester (Flow Laboratories). 
The filter paper was dried overnight at room temperature, and the 
disks of filter paper containing the cells were placed in 
scintillation vials (Scatron, Inc.). Two ml of ScintiVerse E were 
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added to each vial; the vials were capped and allowed to stand at 
room temperature for a minimum of 1 hr. Radioactivity was 
determined with a Packard sc i ntillation counter with 1 min counts. 
NK assay 
Target cells (cells of the erythroleuke mic tumor K562 cell 
line) were incubated in 51Cr for 1 hr, washed in 5 ml cold FBS and 
diluted to a concentration of l x 10 5 cells/ml in RPMI-1640. Four 
x 10 6 PBMC were added to 24-well flat-bottom tissue-culture plates 
along with SE, resuspended in the appropriate molar concentrations 
in cold RPMI-1640 with a final volume in each well of 2 ml and 
incubated in 5% co2' at 37°C for 44 hrs. Initial assays were 
performed with eight SE concentrations (l0 -10 M to 10 -3 M in tenfold 
dilutions), but after establishing active concentrations subsequent 
assays included only four concentrations of SE ( 10 -6 M to 10 -3 M) . 
Following incubation, the cells from each well were centrifuged for 
5 min at 220 x g and 1.4 ml of the supernatant was removed. These 
cell suspensions, in 0.1 ml quantities, were added to triplicate 
wells of a round-bottomed, 96-well plate. The remaining 0.3 ml of 
cell suspension was diluted in equal volume of RPMI-1640 with 20 % 
FBS, mixed well and 0.1 ml was added to 3 additional wells. The 
dilution process was repeated two more times giving the following 
effector:target ratios in each well: 50:1, 25:1, 12.5:1 and 6.25:1. 
An equal volume (0.1 ml) of RPMI- 1640 with 20% FBS was added to 
triplicate wells to quantitate spontaneous (control) lysis from the 
target cells, and 0.1 ml of 0.5 % saponin (a common detergent) was 
added to triplicate wells to determine the maximal amount of 
radioactivity that could be re l eased from target cells . 
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Target cells, 0.1 ml, were added to each well of the tissue 
culture plates and incubated for 4 hrs at 37°C in 5 % C02 • A 0.1 ml 
aliquot of supernatant was removed from each well, and radioactivity 
was determined with a Packard gamma-counter. Cytotoxicity was 
expressed as: 
experimental release - spontaneous release 
% release 
------------------------------------------ X 100 
total release - spontaneous release 
Viability assay 
Cells were prepared and treated as outlined above in the 
preparation of PBMC for the NK assay. Following treatment with SE, 
the PBMC were incubated for 48 hrs at 37°C in 5% C02 • Viability of 
cells undergoing treatment with various concentrations of SE and 
co ntrols (including no SE) was determined using trypan blue. A 
volume of 0.2 ml of trypan blue (0. 2% in PBS) was added to 0.4 ml 
cell suspension and mixed well. Following a 3-min incubation at 
room temperature, the cells were microscopically examined to 
determine viability. Viable cells exclude trypan blue dye while 
dead cells will take up this dye. Viability was expressed as: 
% viability 
FACS analysis 
viable cells 
--------------- x 100 
total cells 
Preliminary analysis of SE's effect on cell surface markers 
was performed using the fluorescence-activated cell sorter (FACS). 
PBMC were treated in SE and incubated identically, as described 
above for the NK and blastogenesis assays, with the exception that 
final incubation periods with K562 target cells and tritiated 
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thymidine, respectively, were omitted. Following incubation, the 
cel ls were labelled with fluorescence-conjugated monoclonal 
antibodies by adding 0.01 ml of the antibody to 0.1 ml of PBMC (2 
x 10 6 cells/ml) in 5-ml polystyrene tubes. The antibody/cell 
suspensions were mixed well on a vortex mixer for approximately 5 
seconds and incubated in the dark for 20 min at room temperature. 
RPMI-1640 (0.8 ml) was added to each tube, and the cell suspension 
was analyzed with a FACS within 48 hrs for fluorescence intensity 
of cell-surface markers. The monoclonal antibodies used were T4-
RDl (helper T cell) (red dye phycoerythrin)/T8-FITC (suppressor and 
cytotoxic T cell) (green dye fluorescein isothiocyanate), Tll-RDl 
(total T cell)/B4-FITC (B cell) and NKH-1-RDl (NK cell)/T8-FITC. 
Labelling and analysis techniques identical to those listed 
above were also performed on PBMC immediately after blood separation 
and prior to any incubation with SE and/or PHA. Flow cytometry was 
completed with an EPICS-C (Coulter Electronics Inc.) equipped with 
an argon laser tuned to 400 mW at the 488 nm line. Cells were 
carried in Isoflow sheath fluid (Coulter), at a flow rate of 2500 
cells/min , through a 76 micron flow tip. Fluorescence data for FITC 
and RDl were obtained using a bit map format gated on a forward 
scatter v, right-angle histogram. The bit map was used to exclude 
debris , dead cells and clumps. However, in the analysis of the PBMC 
treated with PHA, an open-bit map was employed because of the wide 
range in size of the cells following mitogen stimulation. 
Fluorescence signals were processed through a three - decade log 
amplifie r and displayed on a 256-channel scale, and fluorescence 
intensity was standardized using 10 u beads (Immunocheck, Coulter); 
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the peak of the log-green fluorescence was placed in channel 112 by 
a d justing the PMT voltage (appr ox. 1,000). 
with the same settings. 
Statistical analysis 
All samples were run 
All data from NK and blastogenesis studies were tested by the 
analysis of variance using a randomized block design with subjects 
as blocks . Two analyses were run for each of the assays, the first 
with all levels of SE and the smaller sample size and the second 
with the reduced number of SE concentrations and larger sample size. 
Due to the nature of the statistical analysis performed, the 
consu lting statistician, Dr. Sisson, advised that no individual 
error terms be determined. In order to determine significance 
be t ween levels of SE, the Least Significant Difference (LSD) test 
t o compare interaction means was applied between corresponding 
effector:target ratios in the NK assay and PHA concentrations in the 
bl1stogenesis assay. Data from the FACS analysis were not 
stitistically analyzed as this was a preliminary study and, as such, 
emJloyed an extremely small sample size. 
SE-induced suppression of 
lymphocyte DNA synthesis 
CHAPTER IV 
RESULTS 
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PBMC incubated in the highest concentration of SE ( 10 -3 M) 
exhibited significantly (p < 0.05) reduced lymphocyte 
transformation, as expressed by reduced uptake of 3 H-thymidine. 
However, no suppression of uptake was observed at the lower 
concent rati ons of SE (F ig. 1). This SE-induced suppression was 
observed at all concentrations of PHA except for the lowest (0.125 %) 
and was reproducible over a large number (23) of lymphocyte samples 
(Fig.2). 
Inhibition by SE on 
natural killer cell activity 
PBMC, exposed to SE in various concentrations, were incubated 
with 51 Cr-labelled K562 tumor cells. As observed with the 
bla§togefiesis assay, SE at a concentration of ( 10 -3 M) inhibited 
killing of the K562 target cells. This inhibition was significant 
(p < 0.01) at all 4 effector:target cell ratios (Fig. 3) and was 
also confirmed with a larger sample size (Fig. 4) No significant 
suppression of NK activity was observed at lower concentrations of 
SE. 
Viability of cells 
treated with serotonin 
SE-treated PBMC were assayed for viability with the dye, 
trypan blue. Cel l viability was observed to be unaffected by 
treatment in SE even at the highest concentration (Table 1). Ther e 
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Figure 1. SE-induced suppression of incorporation of 3 H-thymidine 
by PHA-stimulated PBMC. SE at 10~ M, elicited significant (p < 
0.05) reduction in the proliferative response at all concentrations 
of PHA except 0.125% while lower SE concentrations were not 
suppressive. (n = 15) 
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Figure 2. SE-induced suppression of incorporation of 3 H-thymidine 
by PHA-s timulated PBMC. SE, 10- 3 M, inhibited (p < 0 . 05) DNA 
synthesis at all concentrations of PHA except O .125%. Lower 
concentrations of SE were not suppressive. (n = 23) 
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Figure 3. SE-induced suppression of natural killer cell activity. 
SE, at 10 -3 M, suppressed (p < 0. 001) 51 Cr release at all 
effec:or: target ratios while lower concentrations of serotonin 
elici t ed no significant suppression of NK activity. (n = 10) 
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SE-induced suppression of PBMC killing of K562 target 
cells. SE, 10- 3 M, significantly suppressed NK activity of PBMC at 
all E:T ratios with no suppression at lower SE concentrations. (n 
= 15) 
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Table 1. Lack of toxicity following incubation with SE for 48 hours. 
Concentration Mean Total Mean 
of SE PBMC Counts a % b 
M (x 10 6 cells/ml) Viability 
0 1. 85 99 + 
10-3 1. 83 99 + 
10-4 1. 83 99 + 
10-5 1. 86 99 
10-6 1.81 99 + 
a. Concentration of PBMC prior to incubation was 2 X 10 -6 cells/ml. 
b. No statistically significant differences between control and SE. 
c. n = 4 
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was no reduction in total number of cells or increase in the 
percentage of dead cells following the incubation period. 
Fluorescence intensity 
of cell surface markers 
FACS analysis of PBMC, incubated with various concentrations 
o f SE and labelled with fluorescence-tagged monoclonal antibodies, 
demonst rated a tendency toward a decrease in fluorescence intensity 
o f all cell surface markers studied; the largest effect observed 
with SE at 10 -3 M. PBMC treated with 10 -4 M SE expressed similar but 
smaller decreases in intensity (Fig. 5). PBMC (1.0 %), treated with 
PHA, expressed similar decreases in fluorescence intensity following 
inc ubation with 10 -3 M and 10 -4 M SE, with 10 -3 M producing the most 
marked effects. PBMC, incubated with 10 -3 M SE but with no PHA, 
demo nstrated the most marked decreases in intensity in the OKT4, 
OKT8 and HNK-1 markers, while smaller decreases were observed with 
OKTll and the IgG marker B4. PBMC, treated with both 10 -3 M SE and 
PHA, demonstrated similar decreases in fluorescence intensity (Fig. 
6 ) . As this portion of the research was performed o nly as a 
pre liminary study, only a small number of subjects was tested and 
the significance of these findings was not analyzed. 
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Figure 5. SE-induced reduction of fluorescence intensity of PBMC 
surface markers. SE at both 10~ Mand 10~ M elicited a decrease in 
the intensity of all markers tested with 10- 3 M having the greatest 
effect. The group significance of all these figures was not 
analyzed due to the small sample size. (n = 4) 
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SE-induced reduction of fluorescence intensity of cell 
surface markers of PBMC ( 1. 0%) stimulated with PHA. SE, at 10 ·3 M, 
produced the most marked reduction in intensity were also observed 
at 10· 4 M with all markers except HNK. Group significance of these 
findings were not analyzed due to the small sample size . (n = 3) 
CHAPTER V 
DISCUSSION 
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Serotonin (SE) has been established as an immunosuppressant 
and, as such, is a possible link in the interactions between the CNS 
and the immune system. This study provides additional evidence of 
the ability of SE to suppress specific immune functions in vitro. 
Slauson et al. ( 1984) demonstrated an SE-induced inhibition 
of 3 H-thymidine incorporation by PBMC stimulated with PHA. This 
inhibition was only observed at a SE concentration of 10 -3 M but was 
highly reproducible over a large range of donors. The present 
investigation confirms the findings of Slauson et al., providing 
substantiating evidence of the ability of SE, at 10 -3 M, to affect 
lymphocyte transformation, although it produced no effect at lower 
co ncentrations. The current study also demonstrates that this 
effec t occurs over a number of PHA concentrations, suggesting that 
the "intensity" of the stimulus to the PBMC does not alter the 
s usceptibility of the cell to SE inhibition. 
Another purpose for attempting to reproduce the study of 
Slauson et al. was to obtain a functional quality control for the 
SE , i.e., to ensure its capability to function as reported in other 
studies. 
In addition to the blastogenesis assay discussed above, the 
effec t of SE on the ability of NK to lyse tumor cells was analyzed. 
SE (10 -3 M) produced a complete inhibition of NK function, as 
measured by lysis of K562 tumor cells. This was not due to the 
toxic effect of SE on the NK cells and was reproducible over a wide 
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range of donors. As discussed in the Results section, lower 
conce ntrations of SE did not alter NK function at all. 
The significance of the findings from both of these assays is 
unclear, as 10 -3 M is a much higher concentration of SE than one 
would expect to find peripherally in vivo. However, various studies 
have demonstrated that the immunomodulatory effects of SE are not 
mediated through neural pathways in the brain but rather through 
peripheral mechanisms directed toward the lymphocyte (see Literature 
Revie w) . It has long been recognized that platelets sequester SE 
v ia an active uptake system that results in relatively low levels 
of SE in the plasma. Moreover, platelets may release SE in response 
to a wide range of biological stimuli, including such events as 
inflammation (Stacey, 1961; Wirz-Justice & Puhringer, 1978). These 
activ ities suggest a possible mechanism by which lympho cytes may 
be exposed t o and inhibited by large concentrations of SE in various 
microenviron ments in vivo . Walker and Codd (1985) hav e suggested 
that platelets provide a pivotal link between the sympathetic fibers 
and va rious immunocompetent cells, in that the platel ets respond to 
norepinephrine by modifying their capacity to sequester and 
metabolize SE. Therefore, norepinephrine changes may alter local 
plasma SE levels and, as a direct result, immune cell fun c ti on . 
Interpreting in vitro data and applying the results to the in 
vivo situation is a questionable practice, and, therefore, it is not 
my purpose to state that 10 -3 M is indeed the concentration in vivo 
necessary for inhibition of DNA transformation and NK activity. 
There are many factors involved that may in fact alter the SE 
conc entration in vitro and result in a much lower functional 
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concentration than was used in the present study. These factors may 
include the presence of monoamine oxidase, the primary SE-
degradatory enzyme, which may be altering the functional quantity 
o:fE SE available, and only at 10 -3 M (initial concentration) is there 
enough SE remaining to elicit the inhibiting response. Also, SE is 
quickly broken down at temperatures employed in the assays, and, 
therefore, the functional level of this substance may be extremely 
depressed. In addition, it has been observed that SE will bind to 
p asma proteins (Gershon et al., 1983) such as those that may be 
present in the FBS used to supplement the assays employed in this 
study and, therefore, may reduce the availability of SE in vitro. 
Jackson et al. (1988) has reported that murine macrophages have a 
specific uptake system for SE. As all the assays in this study 
utilized undepleted PBMC poplulations, this would lead to another 
avenue for the reduction of the SE concentration in the in vitro 
system. In vivo, there may also be other factors that make the 
lymphocyte more responsive to SE at lower concentrations. 
Irrespective of any possible in vivo significance of these 
findings, this study does show that SE has an immunosuppressive 
effect in vitro on PBMC in both DNA transformation and NK activity, 
and, therefore, the cells are capable of responding to this 
stimulus. In addition, SE is noncytotoxic to the PBMC even at high 
(1 o-, M) concentrations. 
The FACS analysis, which indicated that SE may reduce 
fluorescence intensity of markers on the surface of PBMC ( see 
Results), suggests that SE may perhaps be functioning by reducing 
the availability of receptors on the cell surface. This would make 
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the cell unresponsive to stimuli and, therefore, unable to respond 
in the proper fashion. Even though this study has not done the 
necessary analysis to make these conclusions it would provide an 
interesting basis for future studies on the mechanism of SE 
inhibitory effect. 
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APPENDIXES 
Appendix A. Blastogenesis 
statistical analysis 
Table 2. Analysis of SE effect on blastogenesis (n 15) 
Source OF SS MSE F 
Subject 14 4.1338 x 10 10 2.9427 x 10 9 
SE 8 3.7194 x 10 9 4.6493 x 10 8 6.845** 
PHA 4 1.8733 x 10 11 4.6831 x 10 10 689.491** 
SE+ PHA 32 2.1506 x 10 9 6. 7206 x 10 7 < 1 
Exp. Error 616 4.1840 x 10 10 6.7922 x 10 5 
** Significant at (p < 0.01) 
Table 3. Analysis of SE effect on blastogenesis (n 23) 
Source OF SS MSE F 
Subject 22 4.1088 x 10 10 1.8676 x 10 9 
SE 4 1.2349 x 10 10 3.0872 x 10 9 28.507** 
PHA 4 1.9419 x 10 11 4.8547 x 10 10 448.264** 
SE+ PHA 16 6.5424 x 10 9 4.0890 x 10 8 3.776 ** 
Exp. Error 528 5.7182 x 1010 1. 0830 x 10 8 
** Significant at (p < 0.01) 
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Table 4. Least Significant Difference (LSD) between interaction 
means in blastogenesis assays 
Subjects LSD (p < 0.05) LSD (p < 0.01) 
15 3405.40 4475.67 
23 3472. 63 4564.03 
Appendix B. NK 
statistical analysis 
Table 5. Analysis of SE effect on NK (n 10) 
Source DF SS MSE 
Subject 9 10.6541 1.1838 
SE 9 11 . 0360 1.2262 
NK E:T 3 7.9185 2.6395 
SE + NK E:T 27 1.7773 0.0658 
Exp. Error 351 4.9323 0.0141 
** Significant at (p < 0.01) 
Table 6. Analysis of SE effect on NK (n 15) 
Source DF SS MSE 
Subject 14 7.4596 0.5328 
SE 5 16.5781 3.3156 
NK E:T 3 10.3624 3.4541 
SE + NK E:T 15 2.2825 0.1522 
Exp. Error 322 4.2086 0.0131 
** Significant at (p < 0. 01) 
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F 
87.263** 
187.835** 
4.684** 
F 
253.099 ** 
263.672** 
14.220** 
64 
Table 7. Least Significant Difference (LSD) between interaction 
means in NK assays 
Subjects LSD (p < 0.05) LSD (p < 0.01) 
10 0.05999 0.07884 
15 0.04724 0.06209 
